Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHTCF.L Regulatory News (HTCF)

  • There is currently no data for HTCF

Monthly Performance Review

21 May 2015 14:30

RNS Number : 9502N
BlueCrest AllBlue Fund Ltd
21 May 2015
 



FOR IMMEDIATE RELEASE

 

21 May 2015

 

BLUECREST ALLBLUE FUND LIMITED

MONTHLY PERFORMANCE REVIEW FOR APRIL 2015

 

"Choppy markets made for challenging conditions"

 

Choppy markets and some sharp reversals made for challenging conditions in April. BlueCrest AllBlue Fund Limited (BCAB) fell by 1.2% for the month which reduces the year to date return to 1.4% (Sterling Class NAV). The rolling 12 month return was 6.0%. Volatility rose modestly to around 2.5% but remains well within normal historical levels.

 

A number of long established trends saw sharp reversals in April, with some of these accelerating into month end. The US Dollar declined for the first time since the summer of 2014 and bond yields lurched higher, driven by German Bund yields. Some of this reflected macro economic developments, such as generally better economic data in Europe and softer data in the US; some of this was a reflection of over-crowded trades and a scramble for the exits.

 

"Systematic strategies drove the negative return"

 

Five of the seven strategies produced positive returns in April, with a particularly strong performance by BlueCrest Capital International, up 2.8% for the month. Both systematic strategies declined, however, which drove the overall negative return.

 

BlueCrest Capital International saw good gains across all regions. Positioning in Europe, in particular, proved fruitful. Both the sharp weakness in bonds and the general steepening of yield curves suited the fund in Europe but other regions also fared well, especially Asia, where shorts in Australian rates and longs in Japanese volatility both performed strongly. Mortgage backed trading also performed well. The intention is that this MBS strategy will be spun-out in the coming months into a standalone fund which initially will be held by BlueCrest Capital International. However, overall MBS positioning and strategy won't change materially.

 

BlueCrest Quantitative Equity, by contrast, lost 5.8% in April after a strong run over several quarters. The strategy experienced sharp reversals across many signals and factors, largely reflecting a reversal in macro inputs. Momentum related signals, in particular, underperformed and although the fund does not include typical market price momentum signals, the fund nonetheless was exposed to sharp moves which triggered losses. Certain idiosyncratic factors also played a part, such as certain stock exposures in China and unexpected M&A activity in Europe and the US. Whilst disappointing, the drawdown in April is within normal model expectations. Fund returns in May to date have started to recover as market conditions have stabilised.

 

BlueTrend also had a challenging time, mostly in the last week of April, as trends reversed. Losses were seen primarily in foreign exchange and bonds with equities and crops the only strategies that generated profits. Consideration is being given to AllBlue allocating to the 2x version of BlueTrend whilst retaining constant exposure to BlueTrend. This would enable additional cash to be deployed into other funds to enhance returns at the AllBlue level.

 

A handful of small allocation changes were made for May with small increases in BlueCrest Capital International and BlueCrest Equity Strategies at the expense of Credit and Mercantile.

 

"The share price has been well supported"

 

The BCAB share price has been well supported relative to the NAV during April and there was only limited buyback activity as a result. 

Disclaimer:

This document is directed only at: (i) persons having professional experience in matters relating to investments who fall within the definition of "investment professionals" in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005; or (ii) high net worth bodies corporate, unincorporated associations and partnerships and trustees of high value trusts as described in Article 49(2) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and persons who receive this document who do not fall within (i) or (ii) above should not rely on or act upon this document.

 

This document is issued by BlueCrest AllBlue Fund Limited (the "Company") to and for the information of its existing shareholders and does not in any jurisdiction constitute investment advice or an invitation to invest in the shares or any other securities of the Company or any other entity (body corporate or otherwise).

 

The Company has used reasonable care to ensure that the information included in this document is accurate at the date of its issue, but does not undertake to update or revise the information, including any information relating to AllBlue Limited and its underlying funds (the "Funds") provided by BlueCrest Capital Management (UK) LLP or any member of the BlueCrest group of companies (as applicable) ("BlueCrest"), or guarantee the accuracy of such information. To the extent permitted by law neither the Company, the Funds, BlueCrest nor their directors or officers shall be liable for any loss or damage that anyone may suffer in reliance on such information.

 

The information in this document may be changed by the Company at any time. Past performance cannot be relied on as a guide to future performance. The Company's investment strategy is speculative and entails substantial risks. The value of an investment may go down as well as up and some or all of the total amount invested may be lost. This document may not, in whole or in part, directly or indirectly, be taken, transmitted or distributed into the United States of America, its territories or possessions or made available to any national, resident or citizen of the United States of America or any other jurisdiction where applicable laws prohibit its release, distribution or publication. Any failure to comply with these restrictions may be a violation of the law in relevant jurisdictions.

 

JTC (Guernsey) Limited

Secretary

 

Tel: Guernsey 01481 702400

 

END OF ANNOUNCEMENT

E&OE - in transmission

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRXFLFLEEFFBBV
Date   Source Headline
1st Nov 20232:02 pmRNSCompany Update
27th Oct 20235:30 pmRNSHighbridge Tactical Credit Fund
18th Oct 20231:37 pmRNSCompany Update
3rd Oct 20239:36 amRNSDirector Declaration
28th Apr 20232:33 pmRNSTotal Voting Rights
17th Apr 20237:00 amRNSShares in issue
30th Mar 20235:02 pmRNSHalf-year Report
29th Mar 20232:11 pmRNSReturn of Capital
29th Mar 20232:08 pmRNSCash Distribution
17th Mar 20234:35 pmRNSPrice Monitoring Extension
17th Mar 20237:00 amRNSDirector Declaration
16th Mar 20237:00 amRNSCompany Update and Return of Capital Information
15th Mar 20234:36 pmRNS2019 Redemption Portfolio
15th Mar 20234:30 pmRNSNet Asset Value(s)
7th Mar 20234:35 pmRNSPrice Monitoring Extension
13th Feb 20239:00 amRNSChange of Registered Office
2nd Dec 202211:44 amRNSResult of AGM
21st Nov 20223:05 pmRNSHolding(s) in Company
9th Nov 20227:00 amRNSNotice of AGM
8th Nov 20224:00 pmRNSNet Asset Value(s)
8th Nov 20224:00 pmRNS2019 Redemption Portfolio
7th Nov 20225:00 pmRNS2019 Redemption Portfolio
7th Nov 20224:58 pmRNSNet Asset Value(s)
2nd Nov 20227:00 amRNSDistribution
31st Oct 20223:22 pmRNSAnnual Financial Report
20th Oct 202210:47 amRNSAudit Opinion
18th Oct 202211:04 amRNSNet Asset Value(s)
18th Oct 202211:03 amRNS2019 Redemption Portfolio
25th Aug 20224:50 pmRNSNet Asset Value(s)
25th Aug 20224:41 pmRNS2019 Redemption Portfolio
1st Aug 20229:51 amRNS2019 Redemption Portfolio
1st Aug 20229:45 amRNSNet Asset Value(s)
5th Jul 202211:09 amRNS2019 Redemption Portfolio
5th Jul 202211:03 amRNSNet Asset Value(s)
1st Jun 202211:22 amRNSNet Asset Value(s)
1st Jun 202211:20 amRNS2019 Redemption Portfolio
7th Apr 20228:38 amRNSNet Asset Value(s)
7th Apr 20228:24 amRNS2019 Redemption Portfolio
25th Mar 202211:22 amRNSNet Asset Value(s)
25th Mar 202211:15 amRNS2019 Redemption Portfolio
22nd Mar 202211:00 amRNSCash Exit Payment
21st Mar 20223:02 pmRNSInterim Report and Accounts
2nd Mar 202210:23 amRNS2019 Redemption Portfolio
2nd Mar 202210:20 amRNSNet Asset Value(s)
23rd Feb 20224:40 pmRNSSecond Price Monitoring Extn
23rd Feb 20224:36 pmRNSPrice Monitoring Extension
21st Feb 202211:21 amRNSHolding(s) in Company
20th Jan 20225:22 pmRNSHolding(s) in Company
6th Jan 20225:06 pmRNS2019 Redemption Portfolio
6th Jan 20224:59 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.